Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Mechanisms leading to fibroblast accumulation during pulmonary fibrogenesis remain unclear. Although there is in vitro evidence of lung alveolar epithelial-to-mesenchymal transition (EMT), whether EMT occurs within the lung is currently unknown. Biopsies from fibrotic human lungs demonstrate epithelial cells with mesenchymal features, suggesting EMT. To more definitively test the capacity of alveolar epithelial cells for EMT, mice expressing β-galactosidase (β-gal) exclusively in lung epithelial cells were generated, and their fates were followed in an established model of pulmonary fibrosis, overexpression of active TGF-β1. β-gal-positive cells expressing mesenchymal markers accumulated within 3 weeks of in vivo TGF-β1 expression. The increase in vimentin-positive cells within injured lungs was nearly all β-gal-positive, indicating epithelial cells as the main source of mesenchymal expansion in this model. Ex vivo , primary alveolar epithelial cells cultured on provisional matrix components, fibronectin or fibrin, undergo robust EMT via integrin-dependent activation of endogenous latent TGF-β1. In contrast, primary cells cultured on laminin/collagen mixtures do not activate the TGF-β1 pathway and, if exposed to active TGF-β1, undergo apoptosis rather than EMT. These data reveal alveolar epithelial cells as progenitors for fibroblasts in vivo and implicate the provisional extracellular matrix as a key regulator of epithelial transdifferentiation during fibrogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, two important sources of myofibroblasts in SSc are epithelial to mesenchymal transition (EMT) and endothelial to mesenchymal transition (EndoMT).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [95]
In the citing paper
“EMT is an important driver of lung fibrosis, in which alveolar epithelial cells become myofibroblasts (95).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [95]
In the citing paper
“Both processes can be observed in SSc.”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [95]
In the citing paper
“This was demonstrated using alveolar specific lineage tracking, which visualized that alveolar cells started to express αSMA upon overexpression of TGFβ1 (95).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [95]
In the citing paper
“In both processes, respectively epithelial and endothelial cells lose their phenotype and become myofibroblasts.”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [95]
Citations
Cites
1 retracted
RETRACTED: TGF-β1 induces alveolar epithelial to mesenchymal transition in vitro
Yao, H.-W., Xie, Q.-M., Chen, J., Deng, Y., & Tang, H. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.06.019 · Cited by 109
RetractedGeneralized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,409
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
Kim, C. F. B., Jackson, E. L., Woolfenden, A. E., Lawrence, S., Babar, I., Vogel, S., Crowley, D., Bronson, R. T., & Jacks, T. (2005) · Cell · doi:10.1016/j.cell.2005.03.032 · Cited by 2,195
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Self-citationZeisberg, M., Hanai, J.-I., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., & Kalluri, R. (2003) · Nature Medicine · doi:10.1038/nm888 · Cited by 1,346
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Angela Nieto, M., et al. (2005) · Nature · doi:10.1038/nature03688 · Cited by 1,284
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079
Research works printed but not linked: 2
- 10.1172/jci20530 · doi:10.1172/jci20530 · Paper page
- I. Y. Adamson, D. H. Bowden Lab. Invest. 30, 35–42 (1974).
Cited by
Items 901–1,000 of 1,001
Pulmonary fibrosis and COVID-19
Kramer, D., Hilton, R., & Roman, J. (2023) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2023.07.006 · Cited by 15
Kizawa, R., Araya, J., & Fujita, Y. (2023) · Inflammation and Regeneration · doi:10.1186/s41232-023-00295-1 · Cited by 15
Ning, W., Xu, X., Zhou, S., Wu, X., Wu, H., Zhang, Y., Han, J., & Wang, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.998662 · Cited by 15
Lingampally, A., Jones, M. R., Bagari, S., Chen, C., Rivetti, S., & Bellusci, S. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.569865 · Cited by 15
Negative impact of hyperglycaemia on mouse alveolar development
He, M.-Y., Wang, G., Han, S., Li, K., Jin, Y., Liu, M., Si, Z.-P., Ju, W., Liu, G., & Yang, X. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1403683 · Cited by 15
Wang, J., Xue, T., Ye, H., Sang, C., Wu, S., & Li, S. (2020) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2020.103584 · Cited by 15
Cysteine‐rich protein 1 is regulated by transforming growth factor‐β1 and expressed in lung fibrosis
Järvinen, P. M., Myllärniemi, M., Liu, H., Moore, H. M., Leppäranta, O., Salmenkivi, K., Koli, K. M., Latonen, L., Band, A. M., & Laiho, M. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.23000 · Cited by 15
Kebaabetswe, L. P., Haick, A. K., & Miura, T. A. (2013) · Virus Research · doi:10.1016/j.virusres.2013.04.008 · Cited by 15
Update in Diffuse Parenchymal Lung Disease 2008
Behr, J., & Thannickal, V. J. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0011up · Cited by 15
Fukunaga, S., Kakehashi, A., Sumida, K., Kushida, M., Asano, H., Gi, M., & Wanibuchi, H. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.04.014 · Cited by 15
T Cell-mediated biliary epithelial-to-mesenchymal transition in liver allograft rejection
Rygiel, K. A., Robertson, H., Willet, J. D. P., Brain, J. G., Burt, A. D., Jones, D. E. J., & Kirby, J. A. (2010) · Liver Transplantation · doi:10.1002/lt.22029 · Cited by 15
Experimental Study of the Effect of Tack Coats on Interlayer Bond Strength of Pavement
Ali, M. H., Albayati, A. H. K., & Wang, Y. (2023) · Sustainability · doi:10.3390/su15086600 · Cited by 15
Zhang, S., Sun, P., Xiao, X., Hu, Y., Qian, Y. N., & Zhang, Q. (2022) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2022.26.4.239 · Cited by 15
Guo, R., Lv, Y., Ouyang, Y., Liu, S., & Li, D. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25997 · Cited by 15
Ohsaki, H., Hirakawa, E., Nakamura, M., Norimatsu, Y., Kiyomoto, H., & Haba, R. (2011) · Cytopathology · doi:10.1111/j.1365-2303.2010.00791.x · Cited by 15
Mapping Genetic Susceptibility to Stenosis in the Proximal Airway
Sharif, K. F., Tierney, W. S., Davis, R. J., Wohler, E., Sobreira, N. L. D. M., Hillel, A. T., Collins, S. L., Ramirez-Solano, M. A., Sheng, Q., & Gelbard, A. H. (2023) · The Laryngoscope · doi:10.1002/lary.30718 · Cited by 14
Nouri-Keshtkar, M., Taghizadeh, S., Farhadi, A., Ezaddoustdar, A., Vesali, S., Hosseini, R., Totonchi, M., Kouhkan, A., Chen, C., Zhang, J., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.676150 · Cited by 14
Zhang, J., Xu, X., Liang, Y., Wu, X., Qian, Z., Zhang, L., & Wang, T. (2023) · PubMed Central · Cited by 14
New Developments in the Therapy of Pulmonary Fibrosis
Scriabine, A., & Rabin, D. U. (2009) · Advances in pharmacology · doi:10.1016/s1054-3589(08)57011-6 · Cited by 14
Zhou, C., Zhou, D.-C., Zhang, J., Wang, F., Cha, W.-S., Wu, C., & Zhu, Q. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.03.024 · Cited by 14
Jia, R., Li, T., & Wang, N. (2021) · Toxicology · doi:10.1016/j.tox.2021.152891 · Cited by 14
Du, Y., Huang, F., Guan, L., & Zeng, M. (2023) · PubMed Central · doi:10.11817/j.issn.1672-7347.2023.220581 · Cited by 14
Li, L., Wu, Y., & Yang, Y. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1365 · Cited by 14
Zhang, L., Zhao, S., Yuan, L., Wu, H., Jiang, H., & Luo, G. (2016) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12616 · Cited by 14
Evaluation of Epithelial–Mesenchymal Transition Markers in Autoimmune Thyroid Diseases
Sacristan-Gomez, P., Serrano-Somavilla, A., Castro-Espadas, L., de la Blanca, N. S., Sampedro-Nuñez, M. A., de Nova, J. L. M., Molina‐Jiménez, F., Rosell, A., Marazuela, M., & Martínez‐Hernández, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043359 · Cited by 13
Mao, X., Xie, X., Ma, J., Wei, Y., Huang, Z., Wang, T., Zhu, J., Wang, Y., Zhao, H., & Hua, J. (2023) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b23-00071 · Cited by 13
Targeting ATP12A, a Nongastric Proton Pump α Subunit, for Idiopathic Pulmonary Fibrosis Treatment
Abdelgied, M., Uhl, K. L., Chen, O. G., Schultz, C. R., Tripp, K., Peraino, A. M., Paithankar, S., Chen, B., Kakazu, M. T., Castillo-Bahena, A., et al. (2023) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0264oc · Cited by 13
Sandbo, N. K. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-682-5_8 · Cited by 13
Niven, R. W. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.10.004 · Cited by 13
Davoodvandi, A., Asemi, R., Sharifi, M., Reiter, R. J., Matini, A. H., Mirhashemi, S. M., & Asemi, Z. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230409141957 · Cited by 13
Mesenchymal Stem Extracellular Vesicles in Various Respiratory Diseases: A New Opportunity
Hu, Z., Zhu, L., Zhu, Y., & Xu, Y. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s480345 · Cited by 13
Romero‐Valdovinos, M., Bobadilla-Sandoval, N., Flisser, A., & Vadillo‐Ortega, F. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.06.002 · Cited by 13
Immunology of fibrotic lung disease: managing infections whilst preventing autoimmunity?
Hügle, T. (2011) · Journal of Inflammation Research · doi:10.2147/jir.s10602 · Cited by 13
Murray, L. A., Knight, D. A., & Laurent, G. J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374001-4.00015-8 · Cited by 13
Chen, K., Li, Q., Weng, C., Duan, Z., Zhang, D.-D., Chen, Z., Chen, J., & Wang, J. (2018) · Bioscience Reports · doi:10.1042/bsr20180445 · Cited by 13
Pacurari, M., May, I. D., & Tchounwou, P. B. (2016) · Environmental Toxicology · doi:10.1002/tox.22248 · Cited by 13
Kim, S. H., Hwang, S. M., Lee, J. M., Kang, J. H., Chung, I. Y., & Chung, B. G. (2013) · Electrophoresis · doi:10.1002/elps.201200386 · Cited by 13
Epithelial-mesenchymal transition in chronic hypersensitivity pneumonitis.
Yasui, M., Miyazaki, Y., Mitaka, K., Ishizuka, M., Unoura, K., Tamaoka, M., Sumi, Y., & Inase, N. (2012) · PubMed · Cited by 13
Imrecoxib Inhibits Paraquat-Induced Pulmonary Fibrosis through the NF-κB/Snail Signaling Pathway
Jin, H. (2020) · Computational and Mathematical Methods in Medicine · doi:10.1155/2020/6374014 · Cited by 13
Germanguz, I., Aranda, E., Xiong, J. C., Kissel, N., Nichols, A., Gadee, E., & O’Neill, J. D. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/833913 · Cited by 13
Ramalingam, K., Vuthaluru, S., Srivastava, A., Dinda, A. K., & Dhar, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173216 · Cited by 13
Erratum: Targeting the TGFβ signalling pathway in disease
Akhurst, R. J., & Hata, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3878 · Cited by 13
Kim, J., Son, Y., Jung, M. G., Jeong, Y. J., Kim, S., LEE, S.-J., LEE, Y.-J., & Lee, H. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5121 · Cited by 13
Pulmonary fibrosis and exosomes: pathways to treatment
Nija, R. J., & Nithya, T. G. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10855-y · Cited by 12
Enzel, D., Kriventsov, M. A., Sataieva, T., & Malygina, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168946 · Cited by 12
Protective Effects of Extracellular Matrix-Derived Hydrogels in Idiopathic Pulmonary Fibrosis
Evangelista-Leite, D., Carreira, A. C. O., Gilpin, S. E., & Miglino, M. A. (2022) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2020.0357 · Cited by 12
Bufotalin attenuates pulmonary fibrosis via inhibiting Akt/GSK-3β/β-catenin signaling pathway
Yin, J.-Z., Li, Z.-Q., Zhang, X., Wan, Z.-J., Qin, H.-R., Yao, L.-H., Li, B.-L., 高福, & Yang, Y.-Y. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176293 · Cited by 12
Current and Emerging Targeting Strategies for Treatment of Pancreatic Cancer
Baines, A. T., Martin, P. M., & Rorie, C. J. (2016) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.09.006 · Cited by 12
Liu, N., Bowen, C. M., Shoja, M. M., de Pereira, K. L. C., Dongur, L. P., Saad, A. F., Russell, W. K., Broderick, T. C., Fair, J. H., & Fagg, W. S. (2022) · Biomedicines · doi:10.3390/biomedicines10092189 · Cited by 12
Pasanisi, E., Ciavarella, C., Valente, S., Ricci, F., & Pasquinelli, G. (2019) · Ultrastructural Pathology · doi:10.1080/01913123.2019.1673863 · Cited by 12
Ianni, A., Hofmann, M., Kumari, P., Tarighi, S., Al-tamari, H. M., Görgens, A., Giebel, B., Nolte, H., Krüger, M., Salwig, I., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.639162 · Cited by 12
Relaxin as a treatment for musculoskeletal fibrosis: What we know and future directions
Nourmahnad, A., Shariyate, M. J., Khak, M., Grinstaff, M. W., Nazarian, A., & Rodriguez, E. K. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116273 · Cited by 12
Huang, X. (2011) · American Journal of Biomedical Sciences · doi:10.5099/aj110200095 · Cited by 12
New Light is Shed on the Enigmatic Origin of the Lung Myofibroblast
Rosas, I. O., Kottman, R. M., & Sime, P. J. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201308-1494ed · Cited by 12
Fabro, A. T., Minatel, I. O., Rangel, M. P., Halbwedl, I., Parra, E. R., Capelozzi, V. L., & Popper, H. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.06.008 · Cited by 12
Cui, Z. G., Sun, S., Liu, Q., Zhou, X., Gao, S., Peng, P., & Li, Q. (2019) · Biochemistry and Cell Biology · doi:10.1139/bcb-2019-0017 · Cited by 12
Mechanisms on How Matricellular Microenvironments Sustain Idiopathic Pulmonary Fibrosis
Jones, N., Rahar, B., Bernau, K., Schulte, J. J., Campagnola, P. J., & Brasier, A. R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115393 · Cited by 11
Exploring therapeutic targets for molecular therapy of idiopathic pulmonary fibrosis
Li, Y., Jiang, C., Zhu, W., Lu, S., Yu, H., & Meng, L. (2024) · Science Progress · doi:10.1177/00368504241247402 · Cited by 11
The Role of the Myofibroblast in Fibrosis and Cancer Progression
Hinz, B., Darby, I. A., Gabbiani, G., & Desmoulière, A. (2011) · Springer eBooks · doi:10.1007/978-94-007-0659-0_3 · Cited by 11
The involvement of HDAC3 in the pathogenesis of lung injury and pulmonary fibrosis
Yu, H., Liu, S., Wang, S., & Gu, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1392145 · Cited by 11
Activation of mucosal immunity and novel prophylactic and therapeutic strategy in combating COVID-19
Chatterjee, S. K., Saha, S., & Muñoz, M. N. M. (2021) · Exploration of Immunology · doi:10.37349/ei.2021.00025 · Cited by 11
COPD: preclinical models and emerging therapeutic targets
Barreiro, E., Wang, X., & Tang, J. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1667976 · Cited by 11
Yu, Y., Lin, Y., Yang, G., & Tian, L. (2017) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2017.1407978 · Cited by 11
Tanaka, K., Shirai, A., Ito, Y., Namba, T., Tahara, K., Yamakawa, N., & Mizushima, T. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.158 · Cited by 11
Fukui, M., Ogawa, Y., Shimmura, S., Hatou, S., Ichihashi, Y., Yaguchi, S., Hirayama, M., Kawakita, T., & Tsubota, K. (2015) · Modern Rheumatology · doi:10.3109/14397595.2014.1002968 · Cited by 11
Liu, H., Sun, Y., Cai, S., Zhao, C., Xu, X. M., Xu, A., Zhou, H., Yang, C., Gu, X., & Ai, X. (2025) · AAPS PharmSciTech · doi:10.1208/s12249-025-03089-5 · Cited by 11
Li, B., Huang, X., Xu, X., Ning, W., Dai, H., & Wang, C. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4201 · Cited by 11
Ayer, J., & Griffiths, C. E. M. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788015981-00001 · Cited by 10
Tan, W., Wang, Y., Chen, Y., & Chen, C. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10622 · Cited by 10
Layoun, H., Hajal, J., Saliba, Y., Smayra, V., Habr, B., & Farès, N. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155899 · Cited by 10
Epigenetic information loss is a common feature of multiple diseases and aging
Sagy, N., Chang, C., Gal, M., & Bar, D. Z. (2025) · GeroScience · doi:10.1007/s11357-025-01767-7 · Cited by 10
Zhang, Q., An, N., Liu, Y., Zhu, Y., Pan, W., Gu, P., Zhao, J., Pu, Q., & Zhu, W. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1448379 · Cited by 10
Coimbra-Campos, L. M. C., da Silva, W. N., Baltazar, L. M., Costa, P. A. C., Prazeres, P. H. D. M., Picoli, C. C., Costa, A. C., Rocha, B. G. S., Santos, G. S. P., Oliveira, F. M. S., et al. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10181-3 · Cited by 10
Collagen 3D matrices as a model for the study of cell behavior in pulmonary fibrosis
Machahua, C., Vicens‐Zygmunt, V., Ríos-Martín, J., Llatjós, R., Campuzano, I. E., Molina‐Molina, M., & Montes‐Worboys, A. (2022) · Experimental Lung Research · doi:10.1080/01902148.2022.2067265 · Cited by 10
Hippo signaling in mechanobiology: Mechanical control of YAP/TAZ and their roles in disease
Kim, Y., Lee, H., Lee, J.-H., Kim, W., & Cha, B. (2026) · Mechanobiology · doi:10.1177/29780241261430920 · Cited by 10
P27 Promotes TGF-β-Mediated Pulmonary Fibrosis via Interacting with MTORC2
Dai, Y.-H., Li, X., Dong, D.-P., Gu, H., Kong, C.-Y., & Xu, Z. (2019) · Canadian Respiratory Journal · doi:10.1155/2019/7157861 · Cited by 10
A 3D Agent-Based Model of Lung Fibrosis
Cogno, N., Bauer, R., & Durante, M. (2022) · Symmetry · doi:10.3390/sym14010090 · Cited by 10
Lee, J.-U., Chang, H. S., Jung, C. A., Kim, R. H., Park, C., & Park, J. (2020) · Canadian Respiratory Journal · doi:10.1155/2020/3406530 · Cited by 10
Zhou, R., Jin, C., Jiao, L., Zhang, S., Tian, M., Liu, J., Yang, S., Yao, W., & Zhou, F. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110603 · Cited by 10
El-Baz, L. M. F., Shoukry, N. M., Hafez, H. S., Guzy, R. D., & Salem, M. L. (2020) · Iranian Journal of Allergy Asthma and Immunology · doi:10.18502/ijaai.v19i4.4110 · Cited by 10
Richert, E., Papenkort, J., Klettner, A., Tode, J., Koinzer, S., Brinkmann, R., Fink, C., Roeder, T., Lucius, R., & Roider, J. B. (2020) · Lasers in Surgery and Medicine · doi:10.1002/lsm.23288 · Cited by 9
Discoidin domain receptor 2 signaling through PIK3C2α in fibroblasts promotes lung fibrosis
Ling, S., Kwak, D., Takuwa, Y., Ge, C., Franceschi, R. T., & Kim, K. K. (2024) · The Journal of Pathology · doi:10.1002/path.6253 · Cited by 9
Self-citationFibrocytes in the Pathogenesis of Chronic Fibrotic Lung Disease
Loomis-King, H. A., & Moore, B. B. (2013) · Current Respiratory Medicine Reviews · doi:10.2174/1573398x11309010005 · Cited by 9
Abe, S., Sato, S., Aono, Y., Azuma, M., Kishi, M., Koyama, K., Takahashi, N., Kagawa, K., Kawano, H., & Nishioka, Y. (2020) · The Journal of Medical Investigation · doi:10.2152/jmi.67.102 · Cited by 9
He, Y., Cai, Y., Pai, P. M., Ren, X., & Xia, Z. (2021) · Vide Leaf, Hyderabad eBooks · doi:10.37247/up.1.2021.21 · Cited by 9
Cytokine Adsorption to Polymyxin B-Immobilized Fiber: An in vitro Study
Utsunomiya, T., Mimura‐Kimura, Y., Yamamoto, T., Aoe, K., Oishi, K., Kamei, H., Matsunaga, K., Yano, M., & Mimura, Y. (2020) · Blood Purification · doi:10.1159/000510290 · Cited by 9
Genetic Interactions Affect Lung Function in Patients with Systemic Sclerosis
Tyler, A. L., Mahoney, J. M., & Carter, G. W. (2020) · G3 Genes Genomes Genetics · doi:10.1534/g3.119.400775 · Cited by 9
Ojo, O. O., Ajayi, S. B., Nwaechefu, O. O., & Ejidike, I. P. (2019) · Journal of Herbs Spices & Medicinal Plants · doi:10.1080/10496475.2019.1689541 · Cited by 9
Liu, T., Xu, P., Qi, S., Ke, S., Hu, Q., Zhao, P., & Li, J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/8634705 · Cited by 9
(2024) · Springer eBooks · doi:10.1007/978-981-99-9283-6_1305 · Cited by 9
Morphological features of pulmonary fibrosis in workers occupationally exposed to alpha radiation
Sychugov, G. V., Azizova, T. V., Osovets, S. V., Казачков, Е. Л., Vs, R., & Grigoryeva, E. S. (2020) · International Journal of Radiation Biology · doi:10.1080/09553002.2020.1721601 · Cited by 9
Smoking-related interstitial lung disease
Cerri, S., Spagnolo, P., Luppi, F., & Richeldi, L. (2011) · European Respiratory Society eBooks · doi:10.1183/1025448x.10008710 · Cited by 9
Cellular mechanisms in the pathogenesis of interstitial lung diseases
Singh, P., Ali, S. N., Zaheer, S., & Singh, M. P. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154691 · Cited by 9
Kim, B., Jin, H. K., Lee, Y.-J., Kang, G.-Y., Cho, J., & Lee, Y. (2016) · BMC Genetics · doi:10.1186/s12863-016-0338-9 · Cited by 9
Roflumilast-N-oxide Induces Surfactant Protein Expression in Human Alveolar Epithelial Cells Type II
Höhne, K., Schließmann, S. J., Kirschbaum, A., Plönes, T., Müller–Quernheim, J., Tenor, H., & Zissel, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038369 · Cited by 9
Hao, W., Yu, T., Li, W., Wang, G., Hu, H.-X., & Zhou, P.-P. (2024) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2024.28.6.559 · Cited by 9
Aladdin, M., Jian, J., Yang, Q., Chen, L., Finkelman, R. B., & Huang, X. (2012) · American Journal of Industrial Medicine · doi:10.1002/ajim.22114 · Cited by 9
Zhang, A., Zou, Y., Xu, Q., Tian, S., Wang, J., Li, Y., Dong, R., Zhang, L., Jiang, J., Wang, L., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.919388 · Cited by 8
Yan, X., Yang, P., Chen, Y., Wang, Y., Feng, Z., Liu, T., Li, Y., Zhou, C., & Li, M. (2024) · Dose-Response · doi:10.1177/15593258241289829 · Cited by 8
Zhou, Y., Duan, M.-N., Fan, X., Zhao, Y., Wang, C., Wang, T., & Hua, S. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1659142 · Cited by 8
Metadata
- Authors
- Kim, K. K., Kugler, M. C., Wolters, P. J., Robillard, L., Galvez, M. G., Brumwell, A. N., Sheppard, D., & Chapman, H. A.
- Affiliations
- University of California, San Francisco (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-08-29
- Volume
- 103
- Issue
- 35
- Pages
- 13180-13185
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2060126259
- Cited by
- 1,257
- References
- 27
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 51 · 2023: 60 · 2022: 57 · 2021: 62 · 2020: 64 · 2019: 63 · 2018: 73 · 2017: 89 · 2016: 72 · 2015: 68 · 2014: 63 · 2013: 74 · 2012: 92
- FWCI
- 43.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Biogen
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R37HL053949, HL53949, R01HL044712, HL-04055, HL 44712, K08HL004055, R01HL053949)
- National Institute of General Medical Sciences (GM-075419, F32GM075419)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- alveolar epithelial cells, epithelial-mesenchymal transition, pulmonary fibrosis, fibroblast accumulation, fibrogenesis, TGF-β1, extracellular matrix, integrins, fibronectin, fibrin, laminin, collagen, vimentin, apoptosis
- MeSH terms
- Animals, beta-Galactosidase, Cells, Cultured, Collagen, Drug Combinations, Epithelial Cells, Extracellular Matrix, Fibronectins, Humans, Laminin, Mesoderm, Mice, Transgenic, Proteoglycans, Pulmonary Alveoli, Pulmonary Fibrosis, Transforming Growth Factor beta, Apoptosis, Genes, Reporter, Mice, Transforming Growth Factor beta1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.